Phase II study of panitumumab and paclitaxel as first-line treatment in recurrent or metastatic head and neck cancer. TTCC-2009-03/VECTITAX study

Colaboración

Año: 2016

Morillo, ED; Mesia, R; Klain, JCA; Fernandez, SV; Martinez-Galan, J; Borgonon, MP; Gonzalez-Rivas, C; Daroqui, JC; Berrocal, A; Martinez-Trufero, J; Vera, R; Cruz-Hernandez, JJ

Título: ORAL ONCOLOGY

• D1